Johnson & Johnson
Search results
The Ortho-McNeil Pharmaceutical was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases.
Ortho-McNeil-Janssen Pharmaceuticals, Inc is a healthcare company of Johnson & Johnson composed of two divisions: Ortho-McNeil, based in Raritan, NJ (United States); the division is focused on primary care. Janssen, based in Beerse (Belgium); formerly Janssen Pharmaceutica; the division is focused on mental health.
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
In 1993, Ortho Pharmaceutical merged with McNeil Pharmaceutical in 1993 to form Ortho-McNeil Pharmaceutical. In Canada , Ortho Products began operations in Montreal in 1941. The company started with one product and three employees and it was one of the first companies in Canada to make oral contraceptives.
Jun 17, 2011 · About Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) provides medicines for an array of health concerns, including central nervous system disorders, such as schizophrenia and epilepsy; women’s health; urology; gastrointestinal conditions; and infectious diseases.
Company profile page for Ortho-McNeil Pharmaceutical LLC including stock price, company news, executives, board members, and contact information.
Jan 1, 1993 · General Information. Description. Developer of medicines designed to use the best internal and external science to transform how diseases are prevented, intercepted, treated and cured. The company's medicines are tested on laboratories and animals before applying it to humans, enabling consumers to get assurance on quality. Contact Information.
